120 related articles for article (PubMed ID: 2065288)
21. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group.
Brown RA; Wolff SN; Fay JW; Pineiro L; Collins RH; Lynch JP; Stevens D; Greer J; Herzig RH; Herzig GP
Leuk Lymphoma; 1996 Jul; 22(3-4):271-7. PubMed ID: 8819076
[TBL] [Abstract][Full Text] [Related]
22. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.
Michel G; Gluckman E; Esperou-Bourdeau H; Reiffers J; Pico JL; Bordigoni P; Thuret I; Blaise D; Bernaudin F; Jouet JP
J Clin Oncol; 1994 Jun; 12(6):1217-22. PubMed ID: 8201385
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D
Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930
[TBL] [Abstract][Full Text] [Related]
24. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
[TBL] [Abstract][Full Text] [Related]
25. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
[TBL] [Abstract][Full Text] [Related]
26. Age and total-body irradiation in addition to corticosteroid dose are important risk factors for avascular necrosis of the bone.
Jagasia S; Misfeldt A; Griffith M; Jagasia M
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1750-1. PubMed ID: 20849970
[No Abstract] [Full Text] [Related]
27. Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.
Radich JP; Sanders JE; Buckner CD; Martin PJ; Petersen FB; Bensinger W; McDonald GB; Mori M; Schoch G; Hansen JA
J Clin Oncol; 1993 Feb; 11(2):304-13. PubMed ID: 8426208
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic bone marrow transplantation for plasma cell leukemia following melphalan, cyclophosphamide and total body irradiation.
De Bock R; Nobels F; Schoemaker I; Van der Planken M; Peetermans M
Bone Marrow Transplant; 1989 May; 4(3):331. PubMed ID: 2659119
[No Abstract] [Full Text] [Related]
29. [Bone marrow transplantation after intensive chemotherapy].
Masaoka T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1650-5. PubMed ID: 3296959
[TBL] [Abstract][Full Text] [Related]
30. Osteonecrosis of the femoral head after allogeneic bone marrow transplantation.
Torii Y; Hasegawa Y; Kubo T; Kodera Y; Minami S; Morishita Y; Yamada Y; Iwata H
Clin Orthop Relat Res; 2001 Jan; (382):124-32. PubMed ID: 11153979
[TBL] [Abstract][Full Text] [Related]
31. Avascular necrosis following bone marrow transplantation: a case-control study.
Fink JC; Leisenring WM; Sullivan KM; Sherrard DJ; Weiss NS
Bone; 1998 Jan; 22(1):67-71. PubMed ID: 9437515
[TBL] [Abstract][Full Text] [Related]
32. [Course of bone tissue after bone marrow allograft in adolescents with sickle cell disease].
Hernigou P; Bernaudin F
Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(2):138-43. PubMed ID: 7899631
[TBL] [Abstract][Full Text] [Related]
33. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
34. Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Anderson JE; Appelbaum FR; Schoch G; Gooley T; Anasetti C; Bensinger WI; Bryant E; Buckner CD; Chauncey T; Clift RA
J Clin Oncol; 1996 Jan; 14(1):220-6. PubMed ID: 8558201
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission.
Troussard X; Leblond V; Kuentz M; Milpied N; Jouet JP; Cordonnier C; Leporrier M; Vernant JP
J Clin Oncol; 1990 May; 8(5):809-12. PubMed ID: 2185338
[TBL] [Abstract][Full Text] [Related]
36. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation.
Kaste SC; Shidler TJ; Tong X; Srivastava DK; Rochester R; Hudson MM; Shearer PD; Hale GA
Bone Marrow Transplant; 2004 Feb; 33(4):435-41. PubMed ID: 14716354
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies.
Lynch MH; Petersen FB; Appelbaum FR; Bensinger WI; Clift RA; Storb R; Sanders JE; Hansen JA; Buckner CD
Bone Marrow Transplant; 1995 Jan; 15(1):59-64. PubMed ID: 7742756
[TBL] [Abstract][Full Text] [Related]
38. High frequency of extramedullary relapse of acute leukemia after allogeneic bone marrow transplantation.
Lee KH; Lee JH; Kim S; Lee JS; Kim SH; Kim WK
Bone Marrow Transplant; 2000 Jul; 26(2):147-52. PubMed ID: 10918424
[TBL] [Abstract][Full Text] [Related]
39. Effect of high-dose cyclophosphamide and total-body irradiation on left ventricular function in adult patients with leukemia undergoing allogeneic bone marrow transplantation.
Baello EB; Ensberg ME; Ferguson DW; Kugler JW; Gingrich RD; Armitage JO; Klassen LW; Kirchner PT; Kerber RE; Marcus ML
Cancer Treat Rep; 1986 Oct; 70(10):1187-93. PubMed ID: 3530445
[TBL] [Abstract][Full Text] [Related]
40. Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association.
Uderzo C; Valsecchi MG; Bacigalupo A; Meloni G; Messina C; Polchi P; Di Girolamo G; Dini G; Miniero R; Locatelli F
J Clin Oncol; 1995 Feb; 13(2):352-8. PubMed ID: 7844596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
